✦ LIBER ✦

PMS25 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH TNF INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND

✍ Scribed by R Plisko; J Krzystek; P Rys; M Russel-Szymczyk; M Szkultecka-Debek; K Szamotulska

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR22 COST-EFFECTIVENESS OF RITUXIMAB (M

✍ G Lewis; A Kielhorn; A Diamantopoulos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PMS35 Cost-Effectiveness of Tocilizumab

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS54 COST-EFFECTIVENESS OF TOCILIZUMAB

✍ Diamantopoulos, A; Wintfeld, N; Giuliani, G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS31 COST OF TREATMENT COMPARISON OF TN

✍ Scheijbeler, H; Strydom, GD 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMS50 Cost-Effectiveness of Biologic Age

✍ C. Valle-Mercado; M.F. Cubides; M. Parra-Torrado; D. Rosselli 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The cost-effectiveness of TNF-inhibitors

✍ Lekander, Ingrid; BorgstrÃ¶m, Fredrik; Lysholm, JÃ¶rgen; Vollenhoven, Ronald F.; 📂 Article 📅 2012 🏛 Springer 🌐 French ⚖ 426 KB